Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2005-05-31
2005-05-31
LeGuyader, John L. (Department: 1635)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S006120, C435S091100, C435S325000, C435S366000, C536S023100, C536S024310, C536S024330, C536S024500
Reexamination Certificate
active
06900053
ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 2. Methods of using these compounds for modulation of fibroblast growth factor receptor 2 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 2 are provided.
REFERENCES:
patent: 5578566 (1996-11-01), Bottaro et al.
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 6008048 (1999-12-01), Monia et al.
patent: 6054312 (2000-04-01), Larocca et al.
patent: WO 98/13521 (1997-09-01), None
Jen et al. Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies. Stem Cells,2000; 18:307-319.*
Branch, A. A good antisense molecule is hard to find. TIBS, 1998 pp. 45-50.*
Fritz et al. Cationic Polystyrene Nonoparticles: Preparation and Characterization of a Model Drug Carrier System for Antisense Oligonucleotides. Journal of Colloid and Interface Science, 1997; 195:272-288.*
Wilson, S. (1997) Accession No.: 132954 (GenEmbl Database).*
Wilson, S. (1998) Accession No.: 187104 (GenEmbl Database).*
Chenchik et al (2000) Accession No.: AR090312 (GenEmbl Database).*
Powers et al. Fibroblast growth factors, their receptors and signaling. Endocrine-Related Cancer (2000). vol. 7:165-197.*
Yamada et al. Suppression of Glioblastoma Cell Growth Following Antisense Oligonucleotide-Mediated inhibition of Fibroblast Growth Factor Receptor Expression, Glia, 1999 vol. 28:66-76.*
Danilenko,Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor, Toxicol. Pathol., 1999, 27:64-71.
Dionne et al.,Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors, Embo J., 1990, 9:2685-2692.
Dionne et al.,BEK, a receptor for multiple members of the fibroblast growth factor(FGF)family, maps to human chromosome 10q25.3-q26, Cytogenet. Cell. Genet., 1992, 60:34-36.
Hajihosseini et al.,A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes, Proc. Natl. Acad. Sci. U. S. A., 2001, 98:3855-3860.
Houssaint et al.,Related fibroblast growth factor receptor genes exist in the human genome, Proc. Natl. Acad. Sci. U. S. A., 1990, 87:8180-8184.
Ishiwata et al.,Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer, Am. J. Pathol., 1998, 153:213-222.
Lemonnier et al.,Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis, J. Bone Miner. Res., 2001, 16:832-845.
Lorenzi et al.,FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement, Proc. Natl. Acad. Sci. U. S. A., 1996, 93:8956-8961.
Meyers et al.,FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing, Am. J. Hum. Genet., 1996, 58:491-498.
Miki et al.,Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop, Science, 1991, 251:72-75.
Ozawa et al.,Growth factors and their receptors in pancreatic cancer, Teratog. Carcinog. Mutagen., 2001, 21:27-44.
Plomp et al.,Pfeiffer syndrome type 2: further delineation and review of the literature, Am. J. Med. Genet., 1998, 75:245-251.
Post et al.,Keratinocyte growth factor and its receptor are involved in regulating early lung branching, Development, 1996, 122:3107-3115.
Powers et al.,Fibroblast growth factors, their receptors and signaling, Endocr. Relat. Cancer, 2000, 7:165-197.
Ricol et al.,Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer, Oncogene, 1999, 18:7234-7243.
Yamada et al.,Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression, Glia, 1999, 28:66-76.
Yu et al.,Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome, Proc. Natl. Acad. Sci. U. S. A., 2000, 97:14536-14541.
Gibbs Terra C.
ISIS Pharmaceuticals Inc.
LeGuyader John L.
Licata & Tyrrell P.C.
LandOfFree
Antisense modulation of fibroblast growth factor receptor 2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of fibroblast growth factor receptor 2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of fibroblast growth factor receptor 2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3427341